Red biotechnology, often described as medical biotechnology, represents one of the most transformative areas of modern science and healthcare. It encompasses the development of biopharmaceuticals, gene therapies, and personalized medicine strategies that are reshaping treatment approaches for numerous diseases. The global biotechnology sector has experienced rapid growth, driven by advances in molecular biology, genetic engineering, and bioinformatics. Despite its enormous potential, red biotechnology also faces considerable challenges such as high research and development costs, ethical and regulatory complexity, and unequal access to advanced therapies.
This seminar paper aims to examine the relationship of ethical public concerns and their influence on innovation in these fields.
It also aims to examine whether there’s a correlation between the ethical acceptance of human embryo genome editing, trust in regulatory institutions, and the benefit perception. This relationship is investigated among 109 medicine students at the University of Ulm through a quantitative survey. Core questions in the survey were whether they are willing to use techniques of gene editing and especially gene editing of embryos. This was tested under different risk factors. Finally, all participants were asked an open question about what they perceive as the biggest problem with human embryo gene editing.
Table of Contents
1. Introduction
1.1. Background and motivation
1.2. Problem statement and research gap
1.3. Research questions
1.4. Structure of the paper
2. Theoretical framework and literature review
2.1. Biotechnology and ethical considerations
2.2. Innovation ecosystems and technology acceptance
2.3. Hypotheses development
3. Methodology
3.1. Research design and approach
3.2. Data collection
3.3. Data Evaluation
4. Results
4.1. Quantitative findings from survey
4.2. Interaction between ethics and Innovation
4.3. Interaction between ecosystems and Innovation
5. Discussion
5.1. Interpretation of findings
5.2. Implications for innovation and ethics in biotechnology
5.3. Policy and regulatory implications
5.4. Limitations and directions for future research
6. Conclusion
6.1. Summary of Key Findings
6.2. Contributions to research and practice
6.3. Outlook for sustainable innovation in Red Biotechnology
Objectives and Topics
This paper explores the complex interplay between ethical considerations, innovation, and acceptance of human germline gene editing among medical students. It investigates how ethical concerns, trust in regulatory institutions, and scientific knowledge influence the perceived benefits of this technology, ultimately aiming to identify factors that support or hinder its responsible integration into healthcare systems.
- Analysis of ethical frameworks and their role in biotechnology innovation.
- Examination of the "creative destruction" of gene editing in medical ecosystems.
- Empirical quantitative survey on medical students' attitudes toward germline editing.
- Assessment of regulatory governance and its impact on public and professional trust.
- Development of implications for future medical education and policy-making.
Excerpt from the book
1.1. Background and motivation
Medical biotechnology is considered a “technology of hope”, as it utilizes biological resources to create diagnostic and therapeutic products that contribute to disease prevention and treatment, underscoring healthcare as a key global priority (Prajapat & Jain, 2022, p. 217).
Technological progress presents both significant opportunities and complex challenges for global health and society. Among these developments, human genome editing offers remarkable potential to advance medicine and public health. These technologies can be applied to somatic cells (non-heritable), germline cells not intended for reproduction, and germline cells used for reproductive purposes. The possible benefits include innovative approaches for diagnosing, treating, and preventing genetic diseases, novel methods to address infertility, strategies to enhance resistance to illnesses, contributions to vaccine research, and a deeper understanding of human biology (WHO, 2021).
During the COVID-19 pandemic, biotechnology proved its importance not only by providing effective vaccines within record timeframes but also by highlighting the adaptability of biotechnology platforms for future pandemics and rare diseases (Prajapat & Jain, 2022).
Despite all the progress biotechnology has made, there are several ethical concerns when facing specific genetic modifications. The field of human germline editing is particularly sensitive.
Should it be possible to cure certain (deadly) diseases before they even develop? Is a hereditary physical feature that caused one parent significant social pressure or bullying, something that should be considered “treatable” through genetic intervention? Would altering a feature simply to fulfill a parent’s preference also be acceptable, under the argument that it might make life easier? Probably most would agree that a child must be helped if they are deadly ill, and of course, that includes the baby and, therefore, the embryo.
The question is: when do we cross the line? Do we cross the line at therapy or at enhancement? Theoretically we possess the technological capability to do both, the real question is whether we should, and if so, when should we stop (Tingle, 2025, 3:18).
Summary of Chapters
1. Introduction: This chapter introduces the potential of human genome editing in medicine while highlighting the inherent ethical dilemmas and defining the research scope regarding medical students' attitudes.
2. Theoretical framework and literature review: This section covers existing research on biotechnology, ethical frameworks like Utilitarianism and deontology, and theories on innovation ecosystems and technology acceptance.
3. Methodology: This chapter outlines the quantitative survey design, including the data collection process from medical students at the University of Ulm and the statistical evaluation techniques used.
4. Results: This chapter presents the empirical findings from the regression analysis, evaluating how variables like ethical concerns and trust impact the perception of germline editing benefits.
5. Discussion: This section interprets the findings within the context of innovation theory, suggesting policy implications and acknowledging the study's limitations regarding generalizability.
6. Conclusion: The final chapter summarizes the core findings, emphasizes contributions to medical practice, and provides an outlook on the need for balanced, responsible innovation in red biotechnology.
Keywords
Red Biotechnology, Human Genome Editing, Germline Editing, CRISPR, Ethical Concerns, Innovation Ecosystems, Technology Acceptance Model, Medical Students, Regulatory Trust, Sustainable Innovation, Creative Destruction, Benefit Perception, Reproductive Medicine, Genetic Modification, Bioethics
Frequently Asked Questions
What is the core focus of this research paper?
The paper examines the relationship between ethical concerns, trust in regulatory institutions, and the perceived benefits of human embryo genome editing, specifically among medical students.
What are the primary themes discussed in the work?
The work focuses on the intersection of medical biotechnology, bioethics, technology acceptance theories, and the role of innovation ecosystems in healthcare.
What is the main objective or research question?
The study aims to determine if there is a correlation between ethical acceptance, trust in regulatory bodies, and benefit perception of germline editing among future medical practitioners.
Which scientific methodology is employed?
The author uses a quantitative, cross-sectional survey design, utilizing OLS regression models to analyze data collected from 109 medical students.
What topics are covered in the main body of the paper?
The main body addresses the theoretical foundations of gene editing, the results of the student survey, and a detailed discussion on the implications for future policy and sustainable medical innovation.
Which keywords best characterize this study?
Key terms include Red Biotechnology, CRISPR, Germline Editing, Bioethics, Innovation Ecosystems, and Technology Acceptance.
Why were medical students chosen as the target group?
Medical students are identified as future practitioners and "gatekeepers" of these technologies, making their attitudes crucial for the future integration of gene editing into clinical practice.
What did the study conclude regarding the role of ethics?
The study found that ethical concerns act as the strongest negative predictor for the perceived benefits of germline editing, effectively serving as a gatekeeper for the technology's legitimacy.
How does the author interpret the concept of 'creative destruction' in this context?
The author argues that germline editing represents a creative destruction that must balance technological disruption with moral and societal approval to be sustainable.
- Quote paper
- Tessa Weider (Author), 2025, Red Biotechnology between Innovation and Ethics. Human Embryo Editing, Munich, GRIN Verlag, https://www.grin.com/document/1691733
